The NF-κB/Rel family of proteins mediates A β-induced neurotoxicity and glial activation

Molecular Brain Research

Volumn 57, Issue 1, 1998, Pages 63-72

  Bales, Kelly R ^a   Du, Yansheng ^a   Dodel, Richard C ^a,b,d   Yan, Guang Mei ^c   Hamilton Byrd, Elizabeth ^a,b   Paul, Steven M ^a,b  

^a Neuroscience Discovery Research   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

amyloid protein; Alzheimer's disease; Glia activation; I B ; NF B

Indexed keywords

AMYLOID BETA PROTEIN; ANTISENSE OLIGONUCLEOTIDE; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; AMYLOID BETA PROTEIN[1-40]; INTERLEUKIN 1; NEUROTOXIN; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR REL;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FETUS; GLIA; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; ANIMAL; ASTROCYTE; BRAIN CORTEX; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL; NUCLEIC ACID PROBE; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTISENSE ELEMENTS (GENETICS); ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERLEUKIN-1; INTERLEUKIN-6; NERVE DEGENERATION; NEURONS; NEUROTOXINS; NF-KAPPA B; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; RATS;

EID: 0032084331     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00066-7     Document Type: Article

References (53)

1. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. U.S.A. 90:1993;567-571.
2. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 270:1995;286-290.
3. Baeuerle P.A. The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta. 1072:1991;63-80.
4. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell. 87:1996;13-20.
5. Barger S.W., Mattson M.P. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Mol. Brain Res. 40:1996;116-126.
6. 2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9328-9332.
7. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784.
8. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 376:1995;167-170.
9. Behl C., Davis J.B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:1994;817-827.
10. Blank V., Kourilsky P., Israel A. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. TIBS. 17:1992;135-140.
11. Busciglio J., Yeh J., Yankner B.A. Beta-amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61:1993;1565-1568.
12. Citron M., Teplow D.B., Selkoe D.J. Generation of amyloid beta protein from its precursor is sequence specific. Neuron. 14:1995;661-670.
13. Copani A., Koh J.Y., Cotman C.W. Beta-amyloid increases neuronal susceptibility to injury by glucose deprivation. NeuroReport. 2:1991;763-765.
14. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
15. Del Bo R., Angeretti N., Lucca E., De Simoni M.G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188:1995;70-74.
16. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
17. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
18. Grilli M., Chiu J.J., Lenardo M.J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1993;1-62.
19. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B.et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
20. Herrmann M., Lorenz H.M., Voll R., Grunke M., Woith W., Kalden J.R. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22:1994;5506-5507.
21. Higuchi M., Ito T., Iwaki T., Hattori M., Kohsaka S., Niho Y., Sakaki Y. Expression of the α2-macroglobin-encoding gene in rat brain and cultured astrocytes. Gene. 141:1994;155-162.
22. Kaltschmidt B., Baeuerle P.A., Kaltschmidt C. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects Med. 14:1993;171-190.
23. Kaltschmidt C., Kaltschmidt B., Baeuerle P.A. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech. Dev. 43:1993;135-147.
24. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P.A. Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14:1994;3981-3992.
25. Kaltschmidt B., Uherek M., Volk B., Baeuerle P., Kaltschmidt C. Transcription factor NF-kB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer's disease. Proc. Natl. Acad. U.S.A. 94:1997;2642-2647.
26. Koh J.Y., Yang L.L., Cotman C.W. Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
27. Korner M., Tarantino N., Debre P. Constitutive activation of NF-κB in human thymocytes. Biochem. Biophys. Res. Commun. 181:1991;80-86.
28. Lockhart B.P., Benicourt C., Junien J.L., Privat A. Inhibitors of free radical formation fail to attenuate direct beta-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39:1994;494-505.
29. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7951-7955.
30. Lukasiuk K., Kaczmarek L., Condorelli D.F. Inducible and constitutive transcription factor NF-kappa B-like DNA binding activities in rat brain cells cultured in vitro. Neurochem. Int. 26:1995;173-178.
31. Manev H., Favaron M., Vicini S., Guidotti A., Costa E. Glutamate-induced neuronal death in primary cultures of cerebellar granule cells: protection by synthetic derivatives of endogenous sphingolipids. J. Pharmacol. Exp. Ther. 252:1990;419-427.
32. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4245-4249.
33. 2+ homeostasis in Alzheimer's disease. TINS. 16:1993;409-414.
34. Mattson M.P., Tomaselli K.J., Rydel R.E. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621:1993;35-49.
35. Mattson M.P., Goodman Y., Luo H., Fu W., Furukawa K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:1997;681-697.
36. McConkey D.J., Hartzell P., Nicotera P., Orrenius S. Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J. 3:1989;1843-1849.
37. Mrak R.E., Sheng J.G., Griffin W.S. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum. Pathol. 26:1995;816-823.
38. Oltersdorf T., Ward P.J., Henriksson T., Beattie E.C., Neve R., Lieberburg I., Fritz L.C. The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. J. Biol. Chem. 265:1990;4492-4497.
39. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
40. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P.et al. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10016-10020.
41. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
42. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
43. Selkoe D.J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:1994;438-447.
44. Sen R., Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell. 47:1986;921-928.
45. Sisodia S.S., Koo E.H., Beyreuther K., Unterbeck A., Price D.L. Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
46. Strittmatter W.J., Roses A.D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4725-4727.
47. Tewari M., Mohn K.L., Yue F.E., Taub R. Sequence of rat RL/IF-1 encoding an IkappaB, and comparison with related proteins containing notch-like repeats. Nucleic Acids Res. 20:1992;607.
48. Thanos D., Maniatis T. NF-kappa B: a lesson in family values. Cell. 80:1995;529-532.
49. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science. 274:1996;787-789.
50. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science. 274:1996;784-787.
51. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., FitzGerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J. 15:1996;4682-4690.
52. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
53. Zabel U., Baeuerle P.A. Purified human I kappa B can rapidly dissociate the complex of the NF- kappa B transcription factor with its cognate DNA. Cell. 61:1990;255-265.